Copertina

Tumor Microenvironment-Responsive Multinucleated Nanocomplexes Loaded with Carbon Dots for Combined Photothermal/Chemodynamic Therapy of Breast Cancer.

Fuente: PubMed

Salvato in:

Dettagli Bibliografici
Autori principali:	Zhu, Zihan, Zhang, Yan, He, Cui, Jin, Yimin, Bian, Wei, Tang, Xinjing, Wang, Jing
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	ChemMedChem 2025
Soggetti:	Carbon Tumor Microenvironment Humans Quantum Dots Animals Female Breast Neoplasms Antineoplastic Agents Mice Reactive Oxygen Species Photothermal Therapy Cell Proliferation Drug Screening Assays, Antitumor Cell Survival Mice, Inbred BALB C Particle Size
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Aspirin-Inspired 6-O-Carboxymethyl-N-Acetylglucosamine: A potent antitumor agent with enhanced efficacy.
di: Qiao, Ziwen, et al.
Pubblicazione: (2025)

Inhibition of Na,K -ATPase enzyme by tetrodotoxin extract in the breast tumor xenograft Balb/c nu mouse model.
di: Ahrari, Ameneh, et al.
Pubblicazione: (2025)

The Inhibitory Effect and Mechanism of the Histidine-Rich Peptide rAj-HRP from on Human Colon Cancer HCT116 Cells.
di: Zhang, Yuebin, et al.
Pubblicazione: (2024)

Marine Natural Product Chagosendine C Induces Cuproptosis in Colorectal Cancer Cells by Targeting FDX1.
di: Tao, Xiaoyu, et al.
Pubblicazione: (2025)

Synergistic induction of immunogenic cell death and tumor microenvironment remodeling by biotinylated marine polysaccharide nanoparticles for enhanced colorectal cancer therapy.
di: Wang, Hui, et al.
Pubblicazione: (2026)

Cereblon upregulation overcomes thalidomide resistance in multiple myeloma through mitochondrial functional reprogramming.
di: Marquez, Jubert, et al.
Pubblicazione: (2026)

Structure-Activity Relationship Study of Majusculamide D: Overcoming Metabolic Instability and Severe Toxicity with a Fluoro Analogue.
di: Zhao, Xiuhe, et al.
Pubblicazione: (2024)

NQO1-Activatable Circular Antisense Oligonucleotides for Tumor-Cell-Specific Survivin Gene Silencing and Antitumor Therapy.
di: Zhao, Xiaoran, et al.
Pubblicazione: (2025)

Integrating experimental findings and machine learning models to predict the anticancer potential of newly synthesized oversulfated fucoidan.
di: Kocabay, Samet, et al.
Pubblicazione: (2026)

Epac (RAPGEF3) promotes betaglycan expression to mediate ciprofloxacin-induced suppression of cancer cell migration and metastasis: Mechanistic insights and drug repurposing potential.
di: Liu, Hui-Pu, et al.
Pubblicazione: (2025)

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
di: Mao, Churu, et al.
Pubblicazione: (2024)

FL496, an FL118-derived small molecule, induces growth inhibition, senescence, and apoptosis of malignant pleural mesothelioma (MPM) cells, and exhibits anti-MPM tumor efficacy strikingly superior to the pemetrexed-cisplatin combination.
di: Aljahdali, Ieman A M, et al.
Pubblicazione: (2025)

Immunocompetent tumor-on-a-chip: A translational tool for drug screening and cancer therapy.
di: Liang, Anqi, et al.
Pubblicazione: (2025)

Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase Inhibitors.
di: Du, Lin, et al.
Pubblicazione: (2025)

Activation of the γ-secretase/NICD-PXR/Notch pathway induces Taxol resistance in triple-negative breast cancer.
di: Wang, Zuo-Jun, et al.
Pubblicazione: (2024)

Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine derivatives as novel cyclin-dependent kinase 12 (CDK12) inhibitors for the treatment of esophageal squamous cell carcinoma.
di: Cao, Yin, et al.
Pubblicazione: (2025)

Stromal lipid species dictate melanoma metastasis and tropism.
di: Gurung, Shilpa, et al.
Pubblicazione: (2025)

Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.
di: Fang, Zhangyun, et al.
Pubblicazione: (2026)

Preliminary Insights Into the Combined Antitumor Efficacy of Onco-VV-TT and Natural Killer Cells in Glioblastoma.
di: Mirbahari, Seyedeh Nasim, et al.
Pubblicazione: (2026)

Identification of EEF1A1 as a therapeutic target in TNBC: Anticancer action of a novel Penicillide-derived inhibitor through ribosomal protein regulation.
di: Yu, Jing, et al.
Pubblicazione: (2026)

Photoimmunotherapy using indocyanine green-loaded Codium fragile polysaccharide and chitosan nanoparticles suppresses tumor growth and metastasis.
di: Ryu, Dayoung, et al.
Pubblicazione: (2024)

Anticancer Effects of Monacolin X Against Human Liver Cancer Cell Line: Exploring the Apoptosis Using AO/EB and DCFHDA Fluorescent Staining.
di: Jayaraman, Vennila, et al.
Pubblicazione: (2025)

Reduced myogenic differentiation capacity of satellite cell-derived myoblasts in male ICR mice compared with male C57BL/6 and BALB/c mice.
di: Suzuki, Takahiro, et al.
Pubblicazione: (2026)

PSPC1 knockout promotes radiosensitivity, inhibits EMT, and metastasis of nasopharyngeal carcinoma cells.
di: He, Huocong, et al.
Pubblicazione: (2025)

Halorotetin B, A Novel Terpenoid Compound Derived from Marine Ascidian, Suppresses Tumor Growth by Targeting the Cell Cycle Regulator UBE2C.
di: Han, Shanhao, et al.
Pubblicazione: (2026)

Discovery of novel thiosemicarbazone dimers as effective inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) for use in cancer therapy.
di: Wang, Lijun, et al.
Pubblicazione: (2026)

Pyrimidine Nucleosides, Benzoic Acid Derivative, and Bipyridine From the Marine-Derived Streptomyces Sp. DS52.
di: Xia, Meng-de, et al.
Pubblicazione: (2025)

Total syntheses of Kavaratamide A and 5--Kavaratamide A.
di: Ren, Tieshun, et al.
Pubblicazione: (2025)

The Potent Antioxidant 3,5-Dihydroxy-4-Methoxybenzyl Alcohol Reveals Anticancer Activity by Targeting Several Signaling Pathways in Bone Metastatic Human Breast Cancer MDA-MB-231 Cells.
di: Yamaguchi, Masayoshi, et al.
Pubblicazione: (2025)

Design and Synthesis of Marine Sarocladione Derivatives with Potential Anticancer Activity.
di: Liu, Xiao-Mei, et al.
Pubblicazione: (2026)

Bacterial Foreignization Nanosystem Elicits Multi-Phenotypic T Cells for Antitumor Immunity.
di: Zhuang, Wan-Ru, et al.
Pubblicazione: (2025)

A Multisynergistic Strategy for Bone Tumor Treatment: Orchestrating Oxidative Stress and Autophagic Flux Inhibition by Environmental-Response Nanoparticle.
di: Chen, Xiaochen, et al.
Pubblicazione: (2025)

Sclerohumins G-L: Selective cytotoxic diterpenoids featuring a 4/9-fused ring system from the soft coral Sclerophytum humesi.
di: Luu, Phuong Vu, et al.
Pubblicazione: (2026)

Self-Carrier Nanoagonist Enabling Positive Feedback Regulation of Cuproptosis-Immunity for Potent Antitumor Therapy.
di: Jiang, Minhao, et al.
Pubblicazione: (2026)

Prediction of newly synthesized heparin mimic's effects as heparanase inhibitor in cancer treatments via variational quantum neural networks.
di: Kocabay, Samet, et al.
Pubblicazione: (2025)

Preparation of mitochondria-targeted camptothecin derivatives for the imaging and antiproliferation of colorectal cancer.
di: Xu, Chenmeng, et al.
Pubblicazione: (2025)

Saccharina japonica derived fucoidan potentiates immune checkpoint blockade therapy by modulating the survival and differentiation fate of myeloid-derived suppressor cells.
di: Deng, Zhenzhen, et al.
Pubblicazione: (2026)

PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer.
di: Fan, Yizeng, et al.
Pubblicazione: (2025)

Metabolic Blockade-Based Genome Mining of SCSIO 07745: Discovery and Biosynthetic Pathway of Aminoquinolinone Alkaloids Bearing 6/6/5 Tricyclic and 6/6/6/5 Tetracyclic Scaffolds.
di: Li, Kunlong, et al.
Pubblicazione: (2025)

Lysosome-Mitochondria Cascade Targeting Nanoparticle Drives Robust Pyroptosis for Cancer Immunotherapy.
di: Liu, Jianxiong, et al.
Pubblicazione: (2024)